Johns Hopkins HIV GuideBrand Names

HMG CoA Reductase Inhibitors ("Statins")

Janessa M. Smith, PharmD, BCPS, Paul A. Pham, Pharm.D.
HMG CoA Reductase Inhibitors ("Statins") is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Atherosclerosis: fluvastatin, lovastatin
  • Cardiovascular events (secondary prevention): pravastatin; coronary heart disease (primary prevention): pravastatin, simvastatin, fluvastatin, lovastatin
  • Stroke / TIA (prophylaxis): simvastatin, rosuvastatin, atorvastatin
  • Hypercholesterolemia, heterozygous familial: pravastatin (pediatrics), fluvastatin, atorvastatin, lovastatin, rosuvastatin; hypercholesterolemia, homozygous familial: simvastatin, atorvastatin, rosuvastatin
  • Hypercholesterolemia (primary): fluvastatin, rosuvastatin, lovastatin, atorvastatin; hypertriglyceridemia: atorvastatin, rosuvastatin

NON-FDA APPROVED USES

  • Hyperlipidemia associated with ART

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: September 3, 2016

Citation

TY - ELEC T1 - HMG CoA Reductase Inhibitors ("Statins") ID - 545193 A1 - Smith,Janessa,PharmD, BCPS AU - Pham,Paul,Pharm.D. Y1 - 2016/09/03/ PB - Johns Hopkins HIV Guide UR - https://www.unboundmedicine.com/medline/view/Johns_Hopkins_HIV_Guide/545193/all/HMG_CoA_Reductase_Inhibitors__"Statins"_ ER -